[1] Long D, Wang C, Huang Y, et al. Changing epidemiology of inflammatory bowel disease in children and adolescents[J]. Int J Colorectal Dis, 2024,39(1):73.
[2] Chhibba T, Gros B, King J A, et al. Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health[J]. J Crohns Colitis, 2025,19(4):jjaf042.
[3] Vavricka S, Ruiz P A, Scharl S, et al. Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study[J]. BMJ Open, 2017, 7(1):e013477.
[4] Qiu F, Sun Y, Li W, et al. A review on drug-metabolizing enzymes, transporters, and gut microbiota on pharmacokinetics in high-altitude environment[J]. Curr Drug Metab, 2025.
[5] Hausmann M, Seuwen K, de Vallière C, et al. Role of pH-sensing receptors in colitis [J]. Pflugers Arch,2024,476(4):611-622.
[6] Villareal L B, Xue X. The emerging role of hypoxia and environmental factors in inflammatory bowel disease[J]. Toxicol Sci,2024,198(2):169-184.
[7] Bourgonje A R, Kloska D, Grochot-Przeczek A, et al. Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets[J]. Redox Biol,2023,60:102603.
[8] Wu Q, You L, Nepovimova E,et al. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape[J]. J Hematol Oncol,2022,15(1):77.
[9] 周志豪,孙凡丽,江秉华.缺氧诱导因子1在高原病中的作用机制的研究进展[J].四川大学学报(医学版),2024,55(6):1424-1435.
[10] Dai W, Guo R, Na X, et al. Hypoxia and the endometrium: an indispensable role for HIF-1α as therapeutic strategies[J]. Redox Biol,2024,73:103205.
[11] Lu H, Lin J, Xu C,et al. Cyclosporine modulates neutrophil functions via the SIRT6-HIF-1α-glycolysis axis to alleviate severe ulcerative colitis[J]. Clin Transl Med,2021,11(2):e334.
[12] Lun J, Zhang H, Guo J, et al. Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease[J]. Front Pharmacol, 2023,14:1045997.
[13] Yang Y H, Yan F, Shi P S, et al. HIF-1α pathway orchestration by LCN2: a key player in hypoxia-mediated colitis exacerbation[J].Inflammation,2024,47(4):1491-1519.
[14] Yin J, Zhou C, Yang K, et al. Mutual regulation between butyrate and hypoxia-inducible factor-1α in epithelial cell promotes expression of tight junction proteins[J]. Cell Biol Int,2020,44(6):1405-1414.
[15] Xiao J, Guo X, Wang Z. Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery[J]. Front Immunol,2024,15:1385907.
[16] Wang Y, Huo L. Role of TLR4/NF-κB pathway in the damage of acute hypobaric hypoxia to small intestinal mucosa in rats[J]. Gen Physiol Biophys,2021,40(1):79-88.
[17] Wan X, Zhang C, Lei P, et al. Precision therapeutics for inflammatory bowel disease: advancing ROS-responsive nanoparticles for targeted and multifunctional drug delivery[J]. J Mater Chem B, 2025,13(10):3245-3269.
[18] Wang Y, Li M, Zha A. mTOR promotes an inflammatory response through the HIF1 signaling pathway in ulcerative colitis[J]. Int Immunopharmacol,2024,134:112217.
[19] Singhal R, Kotla N K, Solanki S, et al. Disruption of hypoxia-inducible factor-2α in neutrophils decreases colitis-associated colon cancer[J]. Am J Physiol Gastrointest Liver Physiol,2024,326(1):G53-G66.
[20] Wen J, Lyu P, Stolzer I, et al. Epithelial HIF2α expression induces intestinal barrier dysfunction and exacerbation of arthritis[J]. Ann Rheum Dis, 2022,81(8):1119-1130.
[21] Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway[J]. Mol Cell Biol,2020, 40(13):e00099-20.
[22] Huang Y B, Jiang L, Liu X Q, et al. Melatonin alleviates acute kidney injury by inhibiting NRF2/Slc7a11 axis-mediated ferroptosis[J]. Oxid Med Cell Longev, 2022,2022:4776243.
[23] Xu W, Deng H, Hu S, et al. Role of ferroptosis in lung diseases[J]. J Inflamm Res, 2021,14:2079-2090.
[24] Solanki S, Devenport S N, Ramakrishnan SK, et al. Temporal induction of intestinal epithelial hypoxia-inducible factor-2α is sufficient to drive colitis[J]. Am J Physiol Gastrointest Liver Physiol,2019,317(2):G98-G107.
[25] Yagishita Y, McCallum M L, Kensler T W, et al. Constitutive activation of Nrf2 in mice expands enterogenesis in small intestine through negative regulation of math1[J]. Cell Mol Gastroenterol Hepatol,2021,11(2):503-524.
[26] Kopacz A, Kloska D, Klimczyk D, et al. Nrf2 transcriptional activity governs intestine development[J]. Int J Mol Sci,2022,23(11):6175.
[27] Lee T C, Huang Y C, Lu Y Z, et al. Hypoxia-induced intestinal barrier changes in balloonassisted enteroscopy[J]. J Physiol, 2018, 596(15): 3411-3424.
[28] Zhao Y, Tian X, Yan Y, et al. Lithospermic acid alleviates oxidative stress and inflammation in DSS-induced colitis through Nrf2[J]. Eur J Pharmacol,2025,995:177390.
[29] Zhang Y, Wang Y, Yao B, et al. Responses of gut microbiota to altitude in a small mammal on Qinghai-Tibetan Plateau[J]. Comp Biochem Physiol Part D Genomics Proteomics, 2025,55:101467.
[30] Bai X, Liu G, Yang J, et al. Changes in the gut microbiota of rats in high-altitude hypoxic environments[J]. Microbiol Spectr, 2022,10(6):e0162622.
[31] Huang Z, Yang W, Wang X, et al. Industrially produced rice protein ameliorates dextran sulfate sodium-induced colitis via protecting the intestinal barrier, mitigating oxidative stress, and regulating gut microbiota[J]. J Agric Food Chem, 2022,70(16):4952-4965.
[32] Kong J, Xiang Q, Ge W, et al. Network pharmacology mechanisms and experimental verification of licorice in the treatment of ulcerative colitis[J]. J Ethnopharmacol,2024,324:117691.
[33] Potteti H R, Noone P M, Tamatam C R, et al. Nrf2 mediates hypoxia-inducible HIF1α activation in kidney tubular epithelial cells [J]. Am J Physiol Renal Physiol, 2021,320(3):F464-F474.
[34] Zheng J, Kim S J, Saeidi S, et al. Overactivated NRF2 induces pseudohypoxia in hepatocellular carcinoma by stabilizing HIF-1α[J]. Free Radic Biol Med,2023, 194:347-356.
[35] Oh E T, Kim J W, Kim J M, et al. NQO1 inhibits proteasome-mediated degradation of HIF-1α[J]. Nat Commun, 2016,7:13593.
[36] Bae T, Hallis S P, Kwak M K. Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer[J]. Exp Mol Med,2024,56(3):501-514.
[37] Potteti H R, Tamatam C R, Marreddy R,et al. Nrf2-AKT interactions regulate heme oxygenase 1 expression in kidney epithelia during hypoxia and hypoxia-reoxygenation[J]. Am J Physiol Renal Physiol,2016,311(5):F1025-F1034.
[38] Khor T O, Huang M T, Kwon K H, et al. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis[J]. Cancer Res,2006, 66(24):11580-11584.
[39] Bondi C D, Rush B M, Hartman H L, et al. Suppression of NRF2 activity by HIF-1α promotes fibrosis after ischemic acute kidney injury[J]. Antioxidants (Basel), 2022,11(9):1810.
[40] Parveen S M A, Natani S, Sruthi K K, et al. HIF-1α and Nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer[J]. Int J Biochem Cell Biol,2022,147:106232.
[41] Kierans S J, Taylor C T. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology[J]. J Physiol, 2021,599(1):23-37.
[42] Li J, Zou P, Xiao R,et al. Indole-3-propionic acid alleviates DSS-induced colitis in mice through macrophage glycolipid metabolism[J]. Int Immunopharmacol,2025,152:114388.
[43] Chen F, Wang N, Liao J, et al. Esculetin rebalances M1/M2 macrophage polarization to treat sepsis-induced acute lung injury through regulating metabolic reprogramming[J]. J Cell Mol Med,2024,28(21):e70178.
[44] Kumar A, Rahul, Kanika, et al. Multifunctional chrysin-loaded gallic acid-glycerol monostearate conjugate-based injectable hydrogel for targeted inhibition of hypoxia-induced NLRP3 inflammasome in ulcerative colitis[J]. Biomater Sci,2025,13(7):1801-1817.
[45] Zakaria S, Elsebaey S, Allam S, et al. Modulating the Siah2-PHD3-HIF1α axis and/or autophagy potentially retard colon cancer proliferation possibly, due to the damping of colon cancer stem cells[J]. Biomed Pharmacother,2022, 154:113562.
[46] Peng S, Shen L, Yu X, et al. The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis[J]. Front Immunol,2023,14:1200111.